01 /What it is
Setmelanotide is a synthetic cyclic eight amino acid peptide and a selective agonist of the melanocortin 4 receptor (MC4R). It is sold as a prescription medicine (Imcivree) in regulated markets for rare genetic obesity disorders involving the leptin melanocortin pathway and is studied as a research compound at MC4R.
02 /How it works
In research models, Setmelanotide binds MC4R on neurons of the hypothalamus and signals through the melanocortin pathway that processes satiety inputs from leptin. The compound is selective for MC4R over MC1R, MC3R, and MC5R, which sets it apart from earlier melanocortin agonists in the same family.
03 /What researchers explore it for
Researchers have explored Setmelanotide in melanocortin receptor research, in satiety pathway research, and in rare genetic obesity research.
04 /Safety and interactions
Setmelanotide is for laboratory research use only and is not for human consumption. Not medical advice. Not intended to diagnose, treat, cure, or prevent any disease.
05 /Research notes
Peptide family: melanocortin receptor agonists, MC4R selective subclass. Frequently compared with Bremelanotide and Melanotan II in melanocortin pharmacology research. The Apothify library lists Setmelanotide for encyclopedia coverage only because of its prescription status.
Related peptides
Bremelanotide · Melanotan II
